نتائج البحث

'''ليكسيزيناتايد lixisenatide''' هو ناهض لمستقبلات [[GLP-1]] يعطى حقنا لمرة واحدة, يستخدم لعلاج المرض

* <math>s_{i}</math>نسبة الأفراد من الفئة i الذين يصلون الفئة i+1 \end{bmatrix}_{t+1}

| IUPAC_name = 1-[2-(diethylamino)ethyl]- 3-(4-methoxybenzyl)quinoxalin- 2(1''H'')-one | CAS_number = 23465-76-1

...-[(1''S'',2''S'',3''S'')-3-hydroxy-2-[(''S'',''E'')-3-hydroxy-4-phenoxybut-1-enyl]-5-oxocyclopentyl]hepta-4,5-dienoate

| IUPAC_name = 2,2-bis(4-hydroxyphenyl)-2''H''-benzo[''b''][1,4]oxazin-3(4''H'')-one ...= 1/C20H15NO4/c22-15-9-5-13(6-10-15)20(14-7-11-16(23)12-8-14)19(24)21-17-3-1-2-4-18(17)25-20/h1-12,22-23H,(H,21,24)

| IUPAC_name = {[2-(2,4-difluorophenyl)-1,3-''bis''(1''H''-1,2,4-triazol-1-yl)propan-2-yl]oxy}phosphonic acid | C=13 | H=13 | F=2 | N=6 | O=4 | P=1

| IUPAC_name = 4-amino-5-chloro-''N''-(1,2-diethylpyrazolidin-4-yl)-2-methoxybenzamide | C=15 | H=23 | Cl=1 | N=4 | O=2

{[1-(carboxymethyl)tetrazol-5-yl]sulfanylmethyl}-8-oxo- 5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

| InChI = 1/C17H12Cl3N5O2/c18-10-3-1-9(2-4-10)15(26)13-11(19)5-8(6-12(13)20)7-25-16(21)14(17(22)27)23-24-25/h1-6 | StdInChI = 1S/C17H12Cl3N5O2/c18-10-3-1-9(2-4-10)15(26)13-11(19)5-8(6-12(13)20)7-25-16(21)14(17(22)27)23-24-25/h1-6

| IUPAC_name = ''N''-(1-azabicyclo[2.2.2]octan-8-yl)-6-chloro-4-methyl-3-oxo-1,4-benzoxazine-8-carboxamide | C=17 | H=20 | Cl=1 | N=3 | O=3

| IUPAC_name = 3-((3''R'')-3-{[(4-fluorophenyl)sulfonyl]amino]-1,2,3,4-tetrahydro-9''H''-carbazol-9-yl)propanoic acid | C=21 | H=21 | F=1 | N=2 | O=4 | S=1

| IUPAC_name = ''N''-(5,6,7,8-tetrahydronaphthalen-1-yl)-4,5-dihydro-1''H''-imidazol-2-amine | CAS_number = 1082-57-1

| C=17 | H=23 | N=1 | O=4 ...1-13-1-6-14(7-2-13)17(21)22-15-8-3-12(4-9-15)5-10-16(19)20/h3-4,8-9,13-14H,1-2,5-7,10-11,18H2,(H,19,20)

| IUPAC_name = (''RS'')-1-(4-chlorophenyl)-4-dimethylamino-2,3-dimethyl-butan-2-ol | imagename = 1 : 1 mixture (racemate)

| IUPAC_name = 1-[4-(4-chlorophenyl)-2-(2,6-dichlorophenyl)<br>sulfanylbutyl]imidazole | tradename = Gynazole-1

C 1 9 1 5 H 3 N F 4 O 3 · C 7 H 8 O 3 S

...trophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid O3-[3-[4,4-di(phenyl)-1-piperidinyl]propyl] O5-methyl ester ...22-38,28-13-6-4-7-14-28)29-15-8-5-9-16-29/h4-10,12-17,24,33,37H,11,18-23H2,1-3H3

| IUPAC_name = (''RS'')-5-(4-chlorophenyl)-4,5-dihydro-1,3-oxazol-2-amine | C=9 | H=9 | Cl=1 | N=2 | O=1

| IUPACName = (1S,4S)-1,7,7-trimethylbicyclo[2.2.1]heptane (1S,4S)-1,7,7-trimethylbicyclo[2.2.1]heptane

...')-8-chloro-5-(2-dimethylaminoethyl)-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-3-yl] ester ...30-19-13-16(23)7-10-18(19)25(22(20)27)12-11-24(2)3/h5-10,13,20-21H,11-12H2,1-4H3/t20-,21+/m1/s1